Back to results
US 2010/0062444 A1Published application
Tle3 as a marker for chemotherapy
AssigneeApplied Genomics, Inc.
InventorsBrian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
Life of this patent
Estimating the term…
Abstract
Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
Claims11
A method for selecting a chemotherapy for a cancer patient comprising steps of:
- providing a cancer sample from a breast, ovarian, or lung cancer patient;
- determining whether TLE3 is expressed in the cancer sample;
- and
- selecting a taxane or taxane derivative for the cancer patient based upon the presence of TLE3 expression in the cancer sample.
1 more element
Dependencies are inferred from the claim text.